Methyldopa Remedica

Methyldopa, the active ingredient in Methyldopa Remedica, is an alpha‑2 adrenergic agonist presented as an oral tablet for oral use. It is employed to lower elevated blood pressure, including in patients with chronic hypertension and in pregnant women with gestational hypertension.

GNH USA supplies Methyldopa Remedica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methyldopa is an antihypertensive agent that acts on the central sympathetic nervous system to manage high blood pressure.

- Hypertension: reduces systolic and diastolic pressure in adults with primary hypertension. - Gestational hypertension: controls blood pressure in pregnant women where other agents may be contraindicated. - Mild preeclampsia: helps maintain target blood pressure in early‑onset preeclampsia under medical supervision.

Methyldopa may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to discomfort. - Nasal congestion: blockage or stuffiness of the nose. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing faintness. - Liver dysfunction: abnormal liver enzymes or hepatitis. - Hemolytic anemia: destruction of red blood cells leading to fatigue and jaundice.

Before initiating therapy, clinicians should evaluate patient history and monitor for specific concerns.

- Blood pressure monitoring: check regularly to avoid excessive hypotension. - Discontinuation: taper gradually to prevent rebound hypertension. - Liver disease: use with caution in patients with hepatic impairment. - Depression: monitor mood changes, as central acting agents can affect CNS. - Hypersensitivity: avoid if known allergy to methyldopa or related compounds. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Methyldopa can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension or hypertensive crisis. - Clonidine: additive hypotensive effect may lead to dangerous blood pressure drops. - Other antihypertensives: concurrent use can cause excessive hypotension.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance blood‑pressure‑lowering effect. - Beta‑blockers: combined use may require dose adjustments. - NSAIDs: can diminish antihypertensive efficacy. - Tricyclic antidepressants: may increase central side‑effects. - Lithium: possible increase in lithium levels, necessitating monitoring.